1. Home
  2. ACAD

as 05-28-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Founded: 1993 Country:
United States
United States
Employees: N/A City: SAN DIEGO
Market Cap: 2.6B IPO Year: 2004
Target Price: $29.37 AVG Volume (30 days): 1.9M
Analyst Decision: Buy Number of Analysts: 19
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.01 EPS Growth: N/A
52 Week Low/High: $14.65 - $33.99 Next Earning Date: 05-08-2024
Revenue: $813,806,000 Revenue Growth: 56.43%
Revenue Growth (this year): 33.95% Revenue Growth (next year): 11.61%

Stock Insider Trading Activity of ACADIA Pharmaceuticals Inc. (ACAD)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Schneyer Mark C. ACAD EVP, CHIEF FINANCIAL OFFICER May 1 '24 Sell $16.94 3,503 $59,340.82 32,053 SEC Form 4
Teehan Brendan ACAD EVP, COO, HEAD OF COMMERCIAL May 1 '24 Sell $16.94 3,477 $58,900.38 42,133 SEC Form 4
Kihara James ACAD PRINCIPAL ACCOUNTING OFFICER May 1 '24 Sell $16.94 1,326 $22,462.44 14,370 SEC Form 4
DAVIS STEPHEN ACAD CEO May 1 '24 Sell $16.94 11,427 $193,573.38 155,231 SEC Form 4
Teehan Brendan ACAD EVP, COO, HEAD OF COMMERCIAL Apr 5 '24 Sell $17.87 2,568 $45,890.16 38,796 SEC Form 4
DAVIS STEPHEN ACAD CEO Apr 5 '24 Sell $17.87 8,858 $158,292.46 161,983 SEC Form 4
DAVIS STEPHEN ACAD CEO Apr 5 '24 Sell $17.87 17,716 $316,584.92 144,267 SEC Form 4
Kihara James ACAD PRINCIPAL ACCOUNTING OFFICER Apr 5 '24 Sell $17.87 1,028 $18,370.36 13,862 SEC Form 4
Kihara James ACAD PRINCIPAL ACCOUNTING OFFICER Apr 5 '24 Sell $17.87 762 $13,616.94 13,100 SEC Form 4
Schneyer Mark C. ACAD EVP, CHIEF FINANCIAL OFFICER Apr 5 '24 Sell $17.87 2,716 $48,534.92 28,742 SEC Form 4
DAVIS STEPHEN ACAD CEO Mar 25 '24 Sell $17.90 17,714 $317,080.60 118,842 SEC Form 4
Schneyer Mark C. ACAD EVP, CHIEF FINANCIAL OFFICER Mar 25 '24 Sell $17.90 5,434 $97,268.60 26,183 SEC Form 4
Teehan Brendan ACAD EVP, COO, HEAD OF COMMERCIAL Mar 25 '24 Sell $17.90 5,140 $92,006.00 36,340 SEC Form 4
Kihara James ACAD PRINCIPAL ACCOUNTING OFFICER Feb 23 '24 Sell $24.67 474 $11,693.58 11,391 SEC Form 4
Schneyer Mark C. ACAD EVP, CHIEF FINANCIAL OFFICER Feb 23 '24 Sell $24.67 772 $19,045.24 21,067 SEC Form 4
Teehan Brendan ACAD EVP, COO, HEAD OF COMMERCIAL Feb 23 '24 Sell $24.67 624 $15,394.08 31,432 SEC Form 4
DAVIS STEPHEN ACAD CEO Jan 6 '24 Sell $29.96 3,732 $111,810.72 96,521 SEC Form 4
Teehan Brendan ACAD EVP, COO, Head of Commercial Jan 6 '24 Sell $29.96 731 $21,900.76 30,949 SEC Form 4
Kihara James ACAD Principal Accounting Officer Dec 15 '23 Sell $28.30 2,000 $56,600.00 11,025 SEC Form 4
Teehan Brendan ACAD EVP, COO, Head of Commercial Nov 17 '23 Sell $22.64 4,960 $112,294.40 30,393 SEC Form 4
Kihara James ACAD Principal Accounting Officer Nov 17 '23 Sell $22.64 1,985 $44,940.40 13,025 SEC Form 4

Share on Social Networks: